Currently Quantum BioPharma is the largest shareholder and debt holder of Unbuzzd Wellness Inc. Pursuant to the terms of their Agreement, Quantum will receive a 7% royalty on revenue from Unbuzzd ...

Investing.com -- Quantum BioPharma Ltd. (NASDAQ: QNTM) stock fell 5.7% after the company announced it purchased 2,000 shares ...

“The Quantum team and I see the extreme value in GameStop going forward and the deep value the company has with 90% cash and marketable securities on their balance sheet,” said Kevin Malone, Board ...

Quantum BioPharma (QNTM) announced the purchase of 2,000 shares of GameStop (GME) to hold on the Company’s balance sheet as a strategic ...

TORONTO, May 19, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce that after receiving approval from the ...

TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”) is pleased to announce that it has closed the final tranche ...

Quantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United Kingdom Provided by GlobeNewswire Jul 8, 2025, 12:00:00 PM ...

Quantum BioPharma Ltd. announced its plan to issue a special dividend in the form of Contingent Value Rights (CVRs) to holders of its Class B Subordinate Voting Shares, on a 1:1 basis.

Contacts Quantum BioPharma Ltd. Zeeshan Saeed, Founder, CEO and Executive Co-Chairman of the Board, Quantum BioPharma Ltd. Email: [email protected] Telephone: (416) 854-8884 ...

In an expansion of its digital asset portfolio, Quantum BioPharma Ltd. has announced the purchase of an additional $500,000 in Bitcoin and other cryptocurrencies, bringing its total holdings to USD $5 ...

Quiver AI Summary Quantum BioPharma Ltd. has successfully completed its Phase 1 clinical trial of Lucid-21-302, also known as Lucid-MS, a novel compound aimed at treating multiple sclerosis (MS).